Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? (Q42947961)

11 November 2017

1 reference

28 October 2023

1 reference

17436028

title

Imaging in the time of NFD/NSF: do we have to change our routines concerning renal insufficiency? (English)

1 reference

magnetic resonance imaging

11 November 2017

1 reference

9 September 2020

1 reference

9 September 2020

1 reference

4 November 2019

1 reference

17436028

fibrosis

1 reference

1

Georg Bongartz

1 reference

11 November 2017

14 April 2007

1 reference

Magnetic Resonance Materials in Physics, Biology and Medicine

11 November 2017

1 April 2007

6 references

13 March 2019

17 June 2019

4 November 2019

29 May 2020

9 September 2020

28 October 2023

7 references

11 November 2017

13 March 2019

17 June 2019

4 November 2019

29 May 2020

9 September 2020

28 October 2023

20

1 reference

11 November 2017

2

1 reference

11 November 2017

57-62

1 reference

Nephrogenic systemic fibrosis: risk factors and incidence estimation.

11 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadodiamide-associated nephrogenic systemic fibrosis: why radiologists should be concerned

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (omniscan).

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadolinium deposition in nephrogenic fibrosing dermopathy

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Is there a causal relation between the administration of gadolinium based contrast media and the development of nephrogenic systemic fibrosis (NSF)?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Description of 12 cases of nephrogenic fibrosing dermopathy and review of the literature

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Scleromyxoedema-like cutaneous diseases in renal-dialysis patients

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadolinium Chloride Toxicity in the Rat

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadolinium-enhanced magnetic resonance angiography of renal transplants.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Preclinical safety assessment and pharmacokinetics of gadodiamide injection, a new magnetic resonance imaging contrast agent.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Electron microscopic study of Kupffer-cell phagocytosis blockade induced by gadolinium chloride

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Pharmacokinetics of Gd-DTPA in Patients with Chronic Renal Failure

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gd-DOTA: evaluation of its renal tolerance in patients with chronic renal failure

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Nephrogenic systemic fibrosis: A serious late adverse reaction to gadodiamide

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Gadolinium-based contrast media may be nephrotoxic even at approved doses

16 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2797854

Biodistribution of radiolabeled, formulated gadopentetate, gadoteridol, gadoterate, and gadodiamide in mice and rats

16 August 2018

1 reference

12 December 2020

Nephrotoxicity of high-dose gadolinium compared with iodinated contrast

1 reference

12 December 2020

Haemodynamic effects of macrocyclic and linear gadolinium chelates in rats: role of calcium and transmetallation

1 reference

12 December 2020

Structure-activity relationship of macrocyclic and linear gadolinium chelates: investigation of transmetallation effect on the zinc-dependent metallopeptidase angiotensin-converting enzyme

1 reference

12 December 2020

Pharmacokinetics of gadodiamide injection in patients with severe renal insufficiency and patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics of 1M gadobutrol in patients with chronic renal failure

1 reference

12 December 2020

Safety of gadolinium contrast agent in hemodialysis patients

1 reference

12 December 2020

Comparison of Gd DTPA-BMA (Omniscan) versus Gd HP-DO3A (ProHance) retention in human bone tissue by inductively coupled plasma atomic emission spectroscopy

1 reference

12 December 2020

Characterization of Gd3+ and Tb3+ Binding Sites on Ca2+, Mg2+-Adenosine Triphosphatase of Sarcoplasmic Reticulum1

1 reference

12 December 2020

The relationship between thermodynamics and the toxicity of gadolinium complexes

1 reference

12 December 2020

Dissociation of gadolinium chelates in mice: relationship to chemical characteristics

1 reference

12 December 2020

Safety and pharmacokinetic profile of gadobenate dimeglumine in subjects with renal impairment

1 reference

12 December 2020

Comparison of Gd(DTPA-BMA) (Omniscan) versus Gd(HP-DO3A) (ProHance) relative to gadolinium retention in human bone tissue by inductively coupled plasma mass spectroscopy

1 reference

12 December 2020

Gadolinium contrast media are more nephrotoxic than iodine media. The importance of osmolality in direct renal artery injections

1 reference

12 December 2020

Gadolinium is quantifiable within the tissue of patients with nephrogenic systemic fibrosis

1 reference

12 December 2020

10.1007/S10334-007-0071-5

Identifiers

DOI

1 reference

Dimensions Publication ID

11 November 2017

0 references

1 reference

11 November 2017

17436028

1 reference